CN101881755B - Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography - Google Patents

Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography Download PDF

Info

Publication number
CN101881755B
CN101881755B CN 200910031294 CN200910031294A CN101881755B CN 101881755 B CN101881755 B CN 101881755B CN 200910031294 CN200910031294 CN 200910031294 CN 200910031294 A CN200910031294 A CN 200910031294A CN 101881755 B CN101881755 B CN 101881755B
Authority
CN
China
Prior art keywords
esmolol
hydrochlorid
mobile phase
optical isomer
isopropyl alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 200910031294
Other languages
Chinese (zh)
Other versions
CN101881755A (en
Inventor
倪桃
姚晓敏
冒宜兰
郁博媛
冯明声
郑文艳
张璐
曹于平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing hicin pharmaceutical Limited by Share Ltd
Original Assignee
HAICHEN PHARMACEUTICAL CO Ltd NANJING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAICHEN PHARMACEUTICAL CO Ltd NANJING filed Critical HAICHEN PHARMACEUTICAL CO Ltd NANJING
Priority to CN 200910031294 priority Critical patent/CN101881755B/en
Publication of CN101881755A publication Critical patent/CN101881755A/en
Application granted granted Critical
Publication of CN101881755B publication Critical patent/CN101881755B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a method for detecting an esmolol hydrochlorid optical isomer by high efficiency liquid chromatography, which comprises the following steps: (1) the chromatographic conditions are as follows: a chromatographic column adopts cellulose esters as a chiral column of a stationary phase; a mobile phase is normal hexane-isopropanol-diethylamine; and a detecting wavelength is 200nm-240nm; (2) preparing a sample into a solution containing 0.1-2.0mg/mL esmolol hydrochlorid by an organic solvent; and (3) measuring and recording a chromatograph chart. The separation degrees of R-esmolol hydrochlorid and S-esmolol hydrochlorid in the measuring method of the invention are all higher than 1.5 and meet the requirement of Chinese Pharmacopoeia. The method provided by the invention can be simultaneously used for the quantification of the esmolol hydrochlorid optical isomer.

Description

Detect the method for esmolol hydrochlorid optical isomer by high performance liquid chromatography
Technical field
The present invention relates to detect by high performance liquid chromatography the method for esmolol hydrochloride (Esmolol Hydrochloride) optical isomer, say more specifically and detect in the esmolol hydrochlorid optical isomer production run or the method for (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride in the esmolol hydrochlorid optical isomer product.
Background technology
Esmolol hydrochloride has a chiral center, has 2 optical isomers, and its structural formula is respectively:
Figure G2009100312943D00011
Figure G2009100312943D00012
(S)-Esmolol Hydrochloride (R)-Esmolol Hydrochloride
Its chemical name is respectively 4-[(2S)-2-hydroxyl-3-(isopropylamino) propoxyl group] the methyl phenylpropionate hydrochloride, 4-[(2R)-and 2-hydroxyl-3-(isopropylamino) propoxyl group] the methyl phenylpropionate hydrochloride, molecular formula: C 16H 25NO 4HCl, molecular weight: 331.15.Esmolol hydrochloride is a kind of selectivity β of ultrashort effect 1-ARBs does not have intrinsic sympathomimetic acitivity and membrane stabilizing action.Its mechanism of action Main Function is in heart β 1Acceptor has the tranquillization of slowing down and exercise heart rate, reduces blood pressure, and reduces the effect of myocardial consumption of oxygen.The method that a lot of isomeride separate by high performance liquid chromatography is known, but the factors such as mobile phase, solvent, column temperature, chromatographic column have a significant impact for testing result or are not suitable for the target detection thing.
Summary of the invention
The purpose of this invention is to provide the optical isomer purity that detects gained sample in the esmolol hydrochlorid optical isomer chirality is synthetic by high performance liquid chromatography, with the quality of control finished product.
It is that the chiral column of fixedly phase detects that the present invention adopts cellulose esters, the formation of the hole in the cellulose esters class formation and passage and enantioselectivity the isomeride inclusion compound, thereby reach separation.
Mobile phase all has a significant impact (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride degree of separation and peak shape in the experimental result, grope through inventor's experiment, determine with normal hexane-isopropyl alcohol-diethylamine (70~98: 2~30: 0.02~0.5, be preferably 75~90: 10~25: 0.05~0.2, more preferably 80: 20: 0.1) be that the mobile phase effect is fine.Wherein add diethylamine and can improve peak shape.
The selection of solvent and (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride degree of separation are relevant.Determine to adopt n-propanol, isopropyl alcohol, ethanol, normal butyl alcohol, methyl alcohol to use solvent as dissolving through testing, preferably take isopropyl alcohol as solvent.
The actual conditions of the method that detects (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride by high performance liquid chromatography provided by the invention is as follows:
1. chromatographic condition: the chromatographic column adopting cellulose esters is the fixing chiral column of phase; Mobile phase is normal hexane-isopropyl alcohol-diethylamine (70~98: 2~30: 0.02~0.5, be preferably 75~90: 10~25: 0.05~0.2, more preferably 80: 20: 0.1); The detection wavelength is 200nm~240nm (being preferably 210nm~230nm, more preferably about 220nm); Column temperature is 20~45 ℃ (being preferably 30~40 ℃, more preferably 35 ℃); Flow rate of mobile phase is 0.5~2.0mL/min (being preferably 0.8~1.2mL/min, more preferably about 1.0mL/min).
2. the configuration of sample solution: adopt organic solvent (to be preferably selected from n-propanol, isopropyl alcohol, ethanol, normal butyl alcohol, methyl alcohol, isopropyl alcohol more preferably), sample ligand is made as the solution of the solution (preferred 0.5~2.0mg/mL, more preferably 1.0mg/mL) of hydrochloric esmolol optical isomer 0.1~2.0mg/mL.
3. measure: solution is injected high performance liquid chromatograph, the record chromatogram, and analyze.
Adopt this chromatographic condition to measure (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride degree of separation all above 1.5, meet the Chinese Pharmacopoeia requirement.This chromatographic condition can be used for the quantitative of esmolol hydrochlorid optical isomer simultaneously.
Description of drawings
Fig. 1: the high-efficient liquid phase chromatogram that separates (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride according to the condition of embodiment 1.
Fig. 2: the high-efficient liquid phase chromatogram that separates (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride according to the condition of embodiment 2.
Embodiment
Embodiment 1.
Instrument: SHIMADZU LC-10AT high performance liquid chromatograph, SPD-10Avp UV-detector, OV-100 column oven;
Chromatographic column: CHIRAL CEL OD-H chromatographic column (0.46 * 25cm, 5 μ m);
Mobile phase: normal hexane-isopropyl alcohol-diethylamine (80: 20: 0.1)
Column temperature: 35 ℃
Flow velocity: 1.0mL/min
Detect wavelength: 220nm.
The preparation of location solution 1: it is an amount of that precision takes by weighing (R)-Esmolol Hydrochloride, with isopropyl alcohol dissolving and be diluted to 1.0mg/mL;
The preparation of location solution 2: it is an amount of that precision takes by weighing (S)-Esmolol Hydrochloride, with isopropyl alcohol dissolving and be diluted to 1.0mg/mL;
The preparation of biased sample solution: precision takes by weighing (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride is an amount of, dissolves and be diluted to isopropyl alcohol to contain (R)-Esmolol Hydrochloride, each 1.0mg/mL of (S)-Esmolol Hydrochloride;
Measure: respectively get location solution 1, location solution 2 and each 20 μ L of biased sample solution and inject high performance liquid chromatograph, the record chromatogram, spectrogram is seen Fig. 1.The degree of separation of (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride is 5.1.
Embodiment 2.
Instrument: SHIMADZU LC-10AT high performance liquid chromatograph, SPD-10Avp UV-detector, OV-100 column oven;
Chromatographic column: Sino- OD chromatographic column (0.46 * 25cm, 5 μ m);
Mobile phase: normal hexane-isopropyl alcohol-diethylamine (85: 15: 0.1)
Column temperature: 35 ℃
Flow velocity: 1.0mL/min
Detect wavelength: 220nm.
The preparation of location solution 1: it is an amount of that precision takes by weighing (R)-Esmolol Hydrochloride, with isopropyl alcohol dissolving and be diluted to 1.0mg/mL;
The preparation of location solution 2: it is an amount of that precision takes by weighing (S)-Esmolol Hydrochloride, with isopropyl alcohol dissolving and be diluted to 1.0mg/mL;
The preparation of biased sample solution: precision takes by weighing (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride is an amount of, dissolves and be diluted to isopropyl alcohol to contain (R)-Esmolol Hydrochloride, each 1.0mg/mL of (S)-Esmolol Hydrochloride;
Measure: respectively get location solution 1, location solution 2 and each 20 μ L of biased sample solution and inject high performance liquid chromatograph, the record chromatogram, spectrogram is seen Fig. 2.The degree of separation of (R)-Esmolol Hydrochloride, (S)-Esmolol Hydrochloride is 4.9.

Claims (12)

1. detect the method for esmolol hydrochlorid optical isomer by high performance liquid chromatography, specific as follows:
1) chromatographic condition: the chromatographic column adopting cellulose esters is the fixing chiral column of phase; Mobile phase is normal hexane-isopropyl alcohol-diethylamine, and ratio is 70~98: 2~30: 0.02~0.5; The detection wavelength is 200nm~240nm; Column temperature is 20~45 ℃; Mobile phase ratio is 0.5~2.0mL/min;
2) preparation of sample solution: adopt organic solvent that sample ligand is made for the solution of hydrochloric esmolol 0.1~2.0mg/mL, described organic solvent is selected from n-propanol, isopropyl alcohol, ethanol, normal butyl alcohol, methyl alcohol;
3) measure: solution is injected high performance liquid chromatograph, and the record chromatogram is also analyzed.
2. method according to claim 1 is characterized in that described mobile phase normal hexane-isopropyl alcohol-diethylamine ratio is 75~90: 10~25: 0.05~0.2.
3. method according to claim 1 and 2 is characterized in that described mobile phase normal hexane-isopropyl alcohol-diethylamine ratio is 80: 20: 0.1.
4. method according to claim 1, it is characterized in that detecting wavelength is 210nm~230nm.
5. according to claim 1 or 4 described methods, it is characterized in that detecting wavelength is 220nm.
6. method according to claim 1 is characterized in that column temperature is 30~40 ℃.
7. according to claim 1 or 6 described methods, it is characterized in that column temperature is 35 ℃.
8. method according to claim 1 and 2 is characterized in that flow rate of mobile phase is 0.8~1.2mL/min.
9. according to claim 1 or 8 described methods, it is characterized in that flow rate of mobile phase is 1.0mL/min.
10. method according to claim 1 is characterized in that the organic solvent that adopts in the preparation of sample solution is isopropyl alcohol.
11. method according to claim 1 is characterized in that sample solution is formulated as the solution of hydrochloric esmolol optical isomer 0.5~2.0mg/mL.
12. method according to claim 11 is characterized in that sample solution is formulated as the solution of hydrochloric esmolol optical isomer 1.0mg/mL.
CN 200910031294 2009-05-04 2009-05-04 Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography Active CN101881755B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910031294 CN101881755B (en) 2009-05-04 2009-05-04 Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910031294 CN101881755B (en) 2009-05-04 2009-05-04 Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography

Publications (2)

Publication Number Publication Date
CN101881755A CN101881755A (en) 2010-11-10
CN101881755B true CN101881755B (en) 2013-05-29

Family

ID=43053818

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910031294 Active CN101881755B (en) 2009-05-04 2009-05-04 Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography

Country Status (1)

Country Link
CN (1) CN101881755B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102466659A (en) * 2010-11-15 2012-05-23 天津药物研究院 Method for detecting N-(N-benzoyl- phenylalanyl)-phenylalanine dipeptide derivative
BR112013018598A2 (en) 2011-01-27 2016-10-18 Baxter Healthcare Sa pharmaceutical composition, method for treating heart disease, use of (s) -methyl-3- [4- (2-hydroxy-3- [4- (2-hydroxy-3-isopropylamino) propoxy] phenylpropionate, and method for control heart rate
CA2825311A1 (en) 2011-01-27 2012-08-02 Baxter International Inc. Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘忠等.高效液相色谱法测定盐酸艾司洛尔的含量及其有关物质.《中国医院药学杂志》.2006,第26卷(第1期),104-106. *
张莉.高效液相色谱法测定大鼠血清中艾司洛尔.《解放军药学学报》.2001,第17卷(第6期),330-331. *
王贵发.顶空毛细管气相色谱法测定盐酸艾司洛尔有机溶剂残留量.《医药导报》.2008,第27卷(第5期),596-597. *

Also Published As

Publication number Publication date
CN101881755A (en) 2010-11-10

Similar Documents

Publication Publication Date Title
Ali et al. Polysaccharides chiral stationary phases in liquid chromatography
CN104634887A (en) Method for separating and measuring ticagrelor and optical isomer of ticagrelor
Wei et al. Enantioseparation of lomefloxacin hydrochloride by high-speed counter-current chromatography using sulfated-β-cyclodextrin as a chiral selector
US9822089B2 (en) R type of resveratrol dimer, preparation process therefor and purpose thereof in lowering blood sugar level
CN101881755B (en) Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography
CN102706997A (en) Detection method of fasudil hydrochloride-related substance
CN103604895B (en) Method for analytical separation of (-) benzoyl Corey lactone optical isomers by HPLC
Hefnawy et al. Enantioselective high-performance liquid chromatographic method for the determination of baclofen in human plasma
Liu et al. Use of various β-cyclodextrin derivatives as chiral selectors for the enantiomeric separation of higenamine by capillary electrophoresis
CN105784878A (en) Method for analyzing and separating cis-bicyclo[3,2,0]hept-2-ene-6-one enantiomer by HPLC (High Performance Liquid Chromatography)
Zhou et al. High performance liquid chromatographic separation of thirteen drugs collected in Chinese Pharmacopoeia 2010 (Ch. P2010) on cellulose ramification chiral stationary phase
Lv et al. Stereoselectiveseparation of racemic trans-paroxol, N-methylparoxetine and paroxetine containing two chiral carbon centres by countercurrent chromatography
CN103760286A (en) Method for measuring optical purity of solifenacin succinate intermediate by high-performance liquid chromatography
CN101858892B (en) Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography
CN102207494B (en) Method for simultaneously determining four optical isomers of palonosetron hydrochloride
Barbato et al. Enantioselective retention of β-blocking agents on human serum albumin and α1-acid glycoprotein HPLC columns: Relationships with different scales of lipophilicity
CN101706478A (en) Method for testing isomer of palonosetron hydrochloride injection solution
CN103512968B (en) A kind of left nadifloxacin of liquid chromatography for separating and determining L-arginine and the method for optical isomer thereof
CN101769902A (en) Method for analyzing and separating optical isomer of pramipexole dihydrochloride by using HPLC method
CN101609071A (en) A kind of HPLC method analysis separates the method for ivabradine hydrochloride intermediate optical isomer
CN112979511B (en) Method for analyzing and preparing tert-butyl sulfinamide enantiomer by using HPLC
CN103884783B (en) A kind of analyzing detecting method of ivabradine midbody
CN110398541B (en) Method for separating and measuring maropiptan citrate and optical isomer thereof
CN111351886B (en) Method for determining impurity and main medicine content in phenol sulfoethylamine medicine
CN102854261A (en) Method for separating and detecting duloxetine and optical isomer of duloxetine through liquid chromatography

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NANJING HICIN PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: HAICHEN PHARMACEUTICAL CO., LTD., NANJING

CP01 Change in the name or title of a patent holder

Address after: 210046 Jiangsu province Nanjing HENGFA Nanjing economic and Technological Development Zone, Road No. 1

Patentee after: Nanjing hicin pharmaceutical Limited by Share Ltd

Address before: 210046 Jiangsu province Nanjing HENGFA Nanjing economic and Technological Development Zone, Road No. 1

Patentee before: Haichen Pharmaceutical Co., Ltd., Nanjing